Sign In
Get Clay Free →

Suggestions

    Jeffrey Meshulam

    President at Auro Vaccines LLC

    Jeffrey Meshulam is a prominent figure in the biotechnology industry with a wealth of experience and a proven track record of success.

    He currently serves as the President of Auro Vaccines LLC, a position he assumed after Auro Vaccines acquired the assets of Profectus BioSciences, where he was the President.

    Mr. Meshulam co-founded Profectus in 2005, showcasing his entrepreneurial spirit and leadership skills.

    His journey in the biotechnology sector began when he served as the Director of Corporate Development at the Institute of Human Virology from 1996 to 2004.

    Prior to his role at the Institute of Human Virology, he founded Cellular Products, Inc. in 1983 and held various key positions at the company until 1996, including Chairman CEO, President CEO, and Executive Vice-President.

    During his tenure at Cellular Products, Mr. Meshulam led the company in developing, conducting clinical trials, obtaining FDA approval, and marketing blood screening assays for HIV and HTLV-I, as well as commercializing a kit for detecting HIV p24.

    His visionary leadership also facilitated joint development projects with other corporations, resulting in the commercialization of multiple FDA-approved products and over 100 research-use products.

    Furthermore, he briefly served as the President of Northern Scientific, Inc., a company specializing in ophthalmic products, before selling its manufacturing rights to Chiron.

    Mr. Meshulam's educational background includes a Bachelor of Arts in Biology from the State University of New York at Buffalo, highlighting his strong foundation in the life sciences.

    His diverse experiences across different biotechnology organizations underscore his expertise in business development, corporate leadership, and product commercialization within the sector.

    Jeffrey Meshulam
    Add to my network

    Location

    Baltimore, Maryland Area